Annual Current Liabilities
$15.27 M
+$2.98 M+24.30%
31 December 2023
Summary:
Aptose Biosciences annual total current liabilities is currently $15.27 million, with the most recent change of +$2.98 million (+24.30%) on 31 December 2023. During the last 3 years, it has risen by +$8.46 million (+124.15%). APTO annual current liabilities is now at all-time high.APTO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$9.76 M
-$2.95 M-23.23%
30 September 2024
Summary:
Aptose Biosciences quarterly total current liabilities is currently $9.76 million, with the most recent change of -$2.95 million (-23.23%) on 30 September 2024. Over the past year, it has dropped by -$2.62 million (-21.18%). APTO quarterly current liabilities is now -36.09% below its all-time high of $15.27 million, reached on 31 December 2023.APTO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.3% | -21.2% |
| 3 y3 years | +124.2% | +17.6% |
| 5 y5 years | +447.5% | +149.7% |
APTO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +124.2% | -36.1% | +33.5% |
| 5 y | 5 years | at high | +447.5% | -36.1% | +149.7% |
| alltime | all time | at high | +1921.8% | -36.1% | +1884.1% |
Aptose Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.76 M(-23.2%) |
| June 2024 | - | $12.71 M(+4.7%) |
| Mar 2024 | - | $12.14 M(-20.5%) |
| Dec 2023 | $15.27 M(+24.3%) | $15.27 M(+23.3%) |
| Sept 2023 | - | $12.38 M(+3.4%) |
| June 2023 | - | $11.97 M(-3.6%) |
| Mar 2023 | - | $12.42 M(+1.1%) |
| Dec 2022 | $12.28 M(+50.3%) | $12.28 M(+20.0%) |
| Sept 2022 | - | $10.23 M(+9.9%) |
| June 2022 | - | $9.31 M(+27.4%) |
| Mar 2022 | - | $7.31 M(-10.6%) |
| Dec 2021 | $8.17 M(+20.0%) | $8.17 M(-1.5%) |
| Sept 2021 | - | $8.30 M(+7.7%) |
| June 2021 | - | $7.71 M(+43.5%) |
| Mar 2021 | - | $5.37 M(-21.2%) |
| Dec 2020 | $6.81 M(+23.0%) | $6.81 M(+25.1%) |
| Sept 2020 | - | $5.44 M(+2.3%) |
| June 2020 | - | $5.32 M(+20.3%) |
| Mar 2020 | - | $4.43 M(-20.1%) |
| Dec 2019 | $5.54 M(+98.6%) | $5.54 M(+41.7%) |
| Sept 2019 | - | $3.91 M(+21.4%) |
| June 2019 | - | $3.22 M(+8.1%) |
| Mar 2019 | - | $2.98 M(+6.7%) |
| Dec 2018 | $2.79 M(+58.0%) | $2.79 M(+17.7%) |
| Sept 2018 | - | $2.37 M(-1.3%) |
| June 2018 | - | $2.40 M(+8.9%) |
| Mar 2018 | - | $2.21 M(+24.9%) |
| Dec 2017 | $1.76 M(+33.9%) | $1.76 M(+32.2%) |
| Sept 2017 | - | $1.33 M(+32.7%) |
| June 2017 | - | $1.01 M(-42.7%) |
| Mar 2017 | - | $1.75 M(+33.1%) |
| Dec 2016 | $1.32 M(-22.6%) | $1.32 M(-15.0%) |
| Sept 2016 | - | $1.55 M(+11.4%) |
| June 2016 | - | $1.39 M(-2.7%) |
| Mar 2016 | - | $1.43 M(-15.9%) |
| Dec 2015 | $1.70 M(-15.1%) | $1.70 M(+34.2%) |
| Sept 2015 | - | $1.27 M(+2.5%) |
| June 2015 | - | $1.24 M(-43.2%) |
| Mar 2015 | - | $2.18 M(+31.5%) |
| Dec 2014 | $2.01 M(+12.6%) | - |
| Sept 2014 | - | $1.66 M(-7.0%) |
| May 2014 | $1.78 M(+1.1%) | $1.78 M(-34.7%) |
| Feb 2014 | - | $2.73 M(-8.9%) |
| Nov 2013 | - | $2.99 M(+16.8%) |
| Aug 2013 | - | $2.56 M(+45.4%) |
| May 2013 | $1.76 M(-32.7%) | $1.76 M(+25.9%) |
| Feb 2013 | - | $1.40 M(-12.2%) |
| Nov 2012 | - | $1.59 M(+5.7%) |
| Aug 2012 | - | $1.51 M(-42.3%) |
| May 2012 | $2.62 M(+120.5%) | $2.62 M(+64.9%) |
| Feb 2012 | - | $1.59 M(+12.4%) |
| Nov 2011 | - | $1.41 M(+14.3%) |
| Aug 2011 | - | $1.23 M(+4.0%) |
| May 2011 | $1.19 M | $1.19 M(+4.0%) |
| Feb 2011 | - | $1.14 M(-33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2010 | - | $1.71 M(-46.2%) |
| Aug 2010 | - | $3.18 M(+18.0%) |
| May 2010 | $2.70 M(-81.5%) | $2.70 M(+98.2%) |
| Feb 2010 | - | $1.36 M(-27.8%) |
| Nov 2009 | - | $1.88 M(+29.1%) |
| Aug 2009 | - | $1.46 M(-90.0%) |
| May 2009 | $14.57 M(+433.1%) | $14.57 M(+19.1%) |
| Feb 2009 | - | $12.23 M(-0.6%) |
| Nov 2008 | - | $12.30 M(+448.7%) |
| Aug 2008 | - | $2.24 M(-18.0%) |
| May 2008 | $2.73 M(+5.2%) | $2.73 M(+11.0%) |
| Feb 2008 | - | $2.46 M(+18.4%) |
| Nov 2007 | - | $2.08 M(-12.3%) |
| Aug 2007 | - | $2.37 M(-8.8%) |
| May 2007 | $2.60 M(-5.2%) | $2.60 M(+52.7%) |
| Feb 2007 | - | $1.70 M(-26.2%) |
| Nov 2006 | - | $2.30 M(-16.3%) |
| Aug 2006 | - | $2.75 M(+0.6%) |
| May 2006 | $2.74 M(-16.0%) | $2.74 M(-3.2%) |
| Feb 2006 | - | $2.83 M(-78.5%) |
| Nov 2005 | - | $13.14 M(+287.3%) |
| Aug 2005 | - | $3.39 M(+4.1%) |
| May 2005 | $3.26 M(-23.8%) | $3.26 M(-10.4%) |
| Feb 2005 | - | $3.63 M(-8.6%) |
| Nov 2004 | - | $3.98 M(-7.0%) |
| Aug 2004 | - | $4.28 M(+0.0%) |
| May 2004 | $4.28 M(+9.5%) | $4.28 M(-26.2%) |
| Feb 2004 | - | $5.79 M(+25.4%) |
| Nov 2003 | - | $4.62 M(-7.5%) |
| Aug 2003 | - | $4.99 M(+27.8%) |
| May 2003 | $3.91 M(+73.9%) | $3.91 M(+38.5%) |
| Feb 2003 | - | $2.82 M(-10.0%) |
| Nov 2002 | - | $3.13 M(+14.4%) |
| Aug 2002 | - | $2.74 M(+22.0%) |
| May 2002 | $2.25 M(-41.1%) | $2.25 M(+3.5%) |
| Feb 2002 | - | $2.17 M(+6.3%) |
| Nov 2001 | - | $2.04 M(-36.3%) |
| Aug 2001 | - | $3.21 M(-16.0%) |
| May 2001 | $3.81 M(+58.4%) | $3.81 M(+157.4%) |
| Feb 2001 | - | $1.48 M(-25.3%) |
| Nov 2000 | - | $1.98 M(+39.6%) |
| Aug 2000 | - | $1.42 M(-41.0%) |
| May 2000 | $2.41 M(+173.1%) | $2.41 M(+168.8%) |
| Feb 2000 | - | $895.90 K(-51.1%) |
| Nov 1999 | - | $1.83 M(+82.7%) |
| Aug 1999 | - | $1.00 M(+13.8%) |
| May 1999 | $881.70 K(+16.8%) | $881.70 K(+10.8%) |
| Feb 1999 | - | $795.50 K(+22.2%) |
| Nov 1998 | - | $651.00 K(+2.9%) |
| Aug 1998 | - | $632.80 K(-16.2%) |
| May 1998 | $755.20 K(-5.4%) | $755.20 K(+53.6%) |
| Feb 1998 | - | $491.80 K(-41.7%) |
| Nov 1997 | - | $843.30 K(+67.3%) |
| Aug 1997 | - | $504.00 K |
| May 1997 | $798.10 K | - |
FAQ
- What is Aptose Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Aptose Biosciences?
- What is Aptose Biosciences annual current liabilities year-on-year change?
- What is Aptose Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aptose Biosciences?
- What is Aptose Biosciences quarterly current liabilities year-on-year change?
What is Aptose Biosciences annual total current liabilities?
The current annual current liabilities of APTO is $15.27 M
What is the all time high annual current liabilities for Aptose Biosciences?
Aptose Biosciences all-time high annual total current liabilities is $15.27 M
What is Aptose Biosciences annual current liabilities year-on-year change?
Over the past year, APTO annual total current liabilities has changed by +$2.98 M (+24.30%)
What is Aptose Biosciences quarterly total current liabilities?
The current quarterly current liabilities of APTO is $9.76 M
What is the all time high quarterly current liabilities for Aptose Biosciences?
Aptose Biosciences all-time high quarterly total current liabilities is $15.27 M
What is Aptose Biosciences quarterly current liabilities year-on-year change?
Over the past year, APTO quarterly total current liabilities has changed by -$2.62 M (-21.18%)